Skip to main content
VCbacked
Log inGet Started

Distalmotion

Epalinges, Switzerland

Distalmotion is a Swiss medical device company that develops a surgical robot called Dexter to establish a new standard of care.

$150.0M raised
Nov 2025
Series G
Health CareMedicalMedical DevicePersonal HealthRobotics

Top Investors

Venture KickRevival Healthcare Capital415 CapitalFoundation for Innovation and Technology (FIT)BlueOcean Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Distalmotion

How much funding has Distalmotion raised?
Distalmotion has raised $150.0M in total funding. The most recent round was Series G. The last funding was announced in November 2025.
Who are Distalmotion's investors?
Distalmotion's investors include Venture Kick, Revival Healthcare Capital, 415 Capital, Foundation for Innovation and Technology (FIT), BlueOcean Ventures.
Where is Distalmotion headquartered?
Distalmotion is headquartered in Epalinges, Switzerland.
What does Distalmotion do?
Distalmotion is a Swiss medical device company that develops a surgical robot called Dexter to establish a new standard of care.
What stage is Distalmotion at?
Distalmotion is at the Series G stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Distalmotion — Funding & Investors." VCBacked, November 18, 2025, https://www.vcbacked.co/company/distalmotion. Accessed June 4, 2026.
APA
VCBacked. (2025). Distalmotion — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/distalmotion
Wikipedia (cite web)
{{cite web |title=Distalmotion — Funding & Investors |url=https://www.vcbacked.co/company/distalmotion |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K